Cohen & Co. Filing Update by Lester R. Brafman
Ticker: COHN · Form: SC 13D/A · Filed: Dec 3, 2024 · CIK: 1270436
Sentiment: neutral
Topics: 13D-filing, ownership-change, sec-filing
TL;DR
Brafman updated his Cohen & Co. stake filing. Watch for potential moves.
AI Summary
Lester R. Brafman, through Institutional Financial Markets, Inc., has amended their Schedule 13D filing for Cohen & Company Inc. on December 3, 2024. This amendment reflects changes in their beneficial ownership of the company's common stock. The filing details their holdings and intentions regarding the securities.
Why It Matters
This filing update from a significant holder like Lester R. Brafman can signal changes in their investment strategy or confidence in Cohen & Company Inc., potentially influencing market perception.
Risk Assessment
Risk Level: medium — Amendments to 13D filings can indicate shifts in significant shareholder positions or intentions, which may impact the stock price.
Key Players & Entities
- Lester R. Brafman (person) — Filing party and authorized contact
- Cohen & Company Inc. (company) — Subject company
- Institutional Financial Markets, Inc. (company) — Entity associated with Lester R. Brafman's filing
FAQ
What is the primary purpose of this SC 13D/A filing?
The filing is an amendment to a Schedule 13D, indicating changes in the beneficial ownership of Cohen & Company Inc. common stock by Lester R. Brafman.
Who is Lester R. Brafman in relation to Cohen & Company Inc.?
Lester R. Brafman is the individual filing the Schedule 13D/A, indicating he is a significant beneficial owner of Cohen & Company Inc. common stock.
What is the CUSIP number for Cohen & Company Inc. common stock mentioned in the filing?
The CUSIP number for Cohen & Company Inc. common stock is 19249M 102.
When was this amendment filed with the SEC?
This amendment (SC 13D/A) was filed on December 3, 2024.
What is the business address of Cohen & Company Inc. as listed in the filing?
The business address for Cohen & Company Inc. is CIRA CENTRE, 2929 ARCH STREET, 17TH FLOOR, PHILADELPHIA, PA 19104-2870.
Filing Stats: 1,130 words · 5 min read · ~4 pages · Grade level 10.2 · Accepted 2024-12-03 16:17:31
Key Financial Figures
- $0.01 — me of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securiti
Filing Documents
- tm2429874d1_sc13da.htm (SC 13D/A) — 32KB
- 0001104659-24-125085.txt ( ) — 34KB
of the Schedule 13D is hereby supplemented as follows
Item 3 of the Schedule 13D is hereby supplemented as follows: As previously disclosed, on October 22, 2020, Cohen & Company Inc., a Maryland corporation (the “Issuer”), granted to Lester R. Brafman (the “Reporting Person”) 200,000 restricted shares of the Issuer’s common stock, par value $0.01 per share (“Common Stock”), pursuant to the Issuer’s 2020 Long-Term Incentive Plan, as amended. The restrictions will expire with respect to 40,000 of such restricted shares of Common Stock on January 31, 2025 (collectively, the “October 2020 Shares”). Upon the expiration of the restrictions on January 31, 2025 (which date is within 60 days of the date of this Amendment No. 4 to Schedule 13D) with respect to the October 2020 Shares, the Reporting Person will acquire both voting and dispositive control over such shares of Common Stock. Accordingly, the Reporting Person may be deemed to be the beneficial owner of all of the October 2020 Shares (or, an aggregate of 40,000 shares of Common Stock). Such 40,000 shares of Common Stock are the subject of this Amendment No. 4 to Schedule 13D. Item 4. Purpose of Transaction.
of this Schedule 13D is hereby supplemented by the information
Item 4 of this Schedule 13D is hereby supplemented by the information set forth in Item 3 above, which information is incorporated by reference herein. Item 5. Interest in Securities of the Issuer.
of the Schedule 13D is hereby amended and restated in its entirety
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows: The responses of the Reporting Person to rows (7) through (13) of the cover page of this Schedule 13D are incorporated herein by reference. (a) The percentage of ownership indicated in this Schedule 13D is calculated based on 1,950,152 shares of Common Stock outstanding as of November 27, 2024, as provided by the Company. (b) Upon the expiration on January 31, 2025 of the restrictions on the October 2020 Shares, the Reporting Person will have the sole power to vote or direct the vote of, and the sole power to dispose or direct the disposition of, all such shares of Common Stock. (c) The information in Item 4 is incorporated herein by reference. Except as set forth in this Schedule 13D, there have been no transactions in the Common Stock effected during the past 60 days by the Reporting Person. SCHEDULE 13D CUSIP No. 19249M 102 Page 4 of 5 (d) To the knowledge of the Reporting Person, no person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the October 2020 Shares. (e) Not applicable. SIGNATURE After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: December 3, 2024 By: /s/ Lester R. Brafman Name: Lester R. Brafman